Medical Equipment Global News & Press Release Distribution

Medical Equipment

All
APAC

Tigermed Reports 2024 Interim Results

HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its int...

2024-08-28 18:26 1862

Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical

SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its wholly-owned subsidiary, Achieva Medical Limited ("Achieva Medical"), entered ...

2024-08-28 16:40 1198

Sleep Specialists and Industry Leaders Converge at HoneyNaps Symposium

* The 1st HoneyNaps Sleep & Tech Symposium * Presentation of the 'SLEEP 2024 White Paper' and the Latest Advances in Sleep Research & Technology * Unveiling of HoneyNaps' New Brand Identity BOSTON, Aug. 27, 2024 /PRNewswire/ -- HoneyNapsUSA, Inc., an AI-driven sleep data analysis company, p...

2024-08-27 21:00 1846

Sleep Specialists and Industry Leaders Converge at HoneyNaps Symposium

Peijia Medical Announces 2024 Interim Results

HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months endedJune 30, 2024 ("the period") on August 23, 2024. ...

2024-08-26 20:30 2180

Meihua International Medical Technologies Co., Ltd. to Present at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on August 28, 2024

YANGZHOU, China, Aug. 26, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced that Xin "Stev...

2024-08-26 18:00 1611

Ubie Announces Social Impact Framework, Shows Estimated Patient Life Expectancy Impact of 27,000 Years and Approximately $1BN

* Ubie has taken the lead in implementing a new standard of measurement to evaluate health and economic impact for global digital health startups * The framework uses the pharmaceutical industry's standard of Quality-Adjusted Life Years (QALY) to provide a widely-accepted and transparent impa...

2024-08-22 21:30 1398

INTERNATIONAL COLLABORATION AIMS TO COMBAT DIABETES EPIDEMIC IN THE SOUTH PACIFIC

AUCKLAND, New Zealand, Aug. 21, 2024 /PRNewswire/ -- Headquartered in Auckland, New Zealand, Aroa Biosurgery is a global soft tissue reconstruction company which develops and manufactures wound care and surgical products to improve healing in complex wounds and soft tissue reconstruction.

2024-08-21 14:35 1319

INTERNATIONAL COLLABORATION AIMS TO COMBAT DIABETES EPIDEMIC IN THE SOUTH PACIFIC

UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

SHENZHEN, China, Aug. 19, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr.Ehud Baron, a leader in medical technology innovation. This partnership focuses on the jo...

2024-08-19 21:00 1872

De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts

BRISBANE, Australia, Aug. 16, 2024 /PRNewswire/ -- De Motu Cordis (DMC) is pleased to acknowledge and enthusiastically commends the recent U.S. FDA approval of ARS Pharma's Neffy®, the first-ever needle-free intranasal epinephrine delivery device for the treatment of anaphylaxis. This groundbrea...

2024-08-16 18:00 5040

Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China

SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- On August 6, 2024, the msRDN System (SyMapCath I®/ SYMPIONEER S1®), developed by Suzhou/China-based SyMap Medical Ltd. (SyMap Medical), was approved by the National Medical Products Administration (NMPA) ofChina and granted a Class III Medical Devices ...

2024-08-12 13:55 1365

Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo

VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTerm® Smart is launching on Indiegogo as the world's first a...

2024-08-08 23:00 1632

Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo

Concord Medical Regains Compliance with NYSE Minimum Price Requirement

BEIJING, Aug. 7, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it has received a letter from the New York Stoc...

2024-08-07 20:30 3244

Datasea's Digital Technology Subsidiary Selected as Prospective Partner for Future Projects with Subsidiary of China Mobile

The Prospective Partnership with a Subsidiary of China Mobile, one of the World's Largest Mobile Operator, Underscores DTSS' Achievements in 5G-AI Communications BEIJING, Aug. 6, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorpora...

2024-08-06 21:30 2124

Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study

* Lancet Digital Health study highlights Lunit INSIGHT CXR as top performer in TB screening, showing promise for improving detection in high-burden settings SEOUL, South Korea, Aug. 6, 2024 /PRNewswire/ -- Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,...

2024-08-06 21:00 1852

Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study

SURGLASSES Announces Successful First Clinical Implementation of Caduceus S AR Surgical Navigation System in Thailand

ONTARIO, Calif., July 31, 2024 /PRNewswire/ -- Leading augmented reality (AR) medical technology company SURGLASSES today announced that, in collaboration with exclusive distributor Goodlifeintertrade.co. Ltd., it has successfully registered and clinically implemented its AR-based Caduceus S surg...

2024-07-31 21:00 2196

SURGLASSES Announces Successful First Clinical Implementation of Caduceus S AR Surgical Navigation System in Thailand

DermRays Leads the Revolution in Home Hair Removal Devices, Set to Replace Cheap IPL

PLEASANTON, Calif., July 31, 2024 /PRNewswire/ -- DermRays, a leading innovator in skincare technology, is proud to announce its latest breakthrough, spearheading a revolution in home hair removal devices with the introduction of advanced laser technology designed to replace cheap IPL alternative...

2024-07-31 17:10 1298

Baird Medical Announces Engagement and Education Program for the Development of Thyroid Microwave Ablation Technology

FRISCO, Texas, July 30, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical"), a leading developer and provider of microwave ablation ("MWA") medical devices inChina and the United States, today announced a cross-market engagement and education program designed at fostering both kno...

2024-07-30 17:00 1689

Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences

Peijia to maintain exclusive rights in Greater China to commercialize JenaValve's Trilogy Transcatheter Heart Valve (THV) System SUZHOU, China, July 25, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter valve thera...

2024-07-25 20:30 1991

SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US,Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ -- SoniVie , which has developed a novel proprietary Therapeutic Intra-Vascular Ultras...

2024-07-24 19:46 1366

VARON Enters CPAP and BiPAP Machine Market with Feature-Rich "Sunny Grand" Series

SEATTLE, July 18, 2024 /PRNewswire/ -- VARON , a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line ofCPAP (continuous positive airway pressure)

2024-07-19 01:30 1340

1 2 345 6 7 ... 43

Week's Top Stories

Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies

[Picked up by 283 media titles]

2024-11-20 09:00